Case Study: Avidity Biosciences raises $16M in Series B financing with ShareVault

Avidity Biosciences Used ShareVault to Raise $16 Million in a Series B Financing

Avidity Biosciences, a privately held biotech developing Antibody‑siRNA Conjugates (ASC™), faced a critical challenge when preparing for a Series B financing: there was no central repository for its intellectual property, no visibility into investor activity, and no way to customize or revoke document access once files were shared. They needed a secure, easy‑to‑use platform to organize and control sensitive documents while collaborating with partners across countries and time zones.

Avidity chose ShareVault for its intuitive interface, granular permissioning, and advanced analytics. ShareVault provided a controlled central vault where the team could track who viewed which documents, make one‑off permission exceptions, and instantly manage or revoke access. The platform’s security and usability helped streamline investor interactions and supported Avidity’s successful $16 million Series B raise.

Avidity Biosciences

Leigh Elkolli

Director of Finance